<DOC>
	<DOC>NCT02294097</DOC>
	<brief_summary>The risk-benefit of surveillance-protocol biopsy (SPBx) in kidney transplantation remains unclear. The study aims to compare outcomes of recipients with SPBx approach to recipients with standard approach which allograft biopsy was performed only when indicated.</brief_summary>
	<brief_title>Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation</brief_title>
	<detailed_description>The present randomized-controlled trial in kidney transplant patients aims to compare the outcomes and complications between who underwent immunosuppessive drug modification under surveillance-protocol biopsy and who underwent immunosuppressive drug modification following tough level only.</detailed_description>
	<criteria>All kidney transplant recipients underwent transplantation at Chulalongkorn University Pregnancy Recipients who cannot withhold aspirin, clopidogrel, warfarin, etc. Noncooperated recipients</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>